Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03489148 · ClinicalTrials.gov registry record · NA
Implications of Tamarkoz® on Stress, Emotion, Spirituality and Heart Rate
A NA study, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 103
- Enrollment target
NCT03489148 is a NA study that has completed, run by Loma Linda University. The registered enrollment target is 103 participants.
The verdict
NCT03489148, a NA study, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 103 participants
- Enrollment target
Study Summary
Depression, anxiety, hopelessness, poor sleep quality, somatic pain, high risk of substance abuse, and suicide ideation are positively correlated with perceived stress. Spirituality and positive emotions have profound, positive impacts on health and reduce perceived stress. The current study is an exploration of Tamarkoz®, a Sufi practice that is a method to concentrate, as a pathway by which spirituality and positive emotions effect perceived stress. Tamarkoz® incorporates physical, emotional, and spiritual aspects of an individual. In its current form, it includes Movazaneh® which is movement balancing developed by the Sufi Master, Professor Nader Angha. Movazaneh® movements direct concentration of the mind to a state of collectiveness and activates electromagnetic centers in the body, which are said to develop spirituality in an individual. A national survey of college students indicated that over 80% have interest in spiritual development. Participants were recruited from the University of California, Berkeley for an 18-week quasi-experimental study with pretest-posttest and follow-up in three groups. Assessments were conducted with blood pressure, heart rate, the 10-item perceived stress scale, the 38-item dispositional positive emotions scale, and the 16-item daily spiritual experiences scale in a Tamarkoz® group, a wait-list control, and a third group utilizing the campus health center's stress management resources. Blood pressure and heart rate measurements were taken by the researcher using a validated home monitoring device. Additionally, all participants provided 3 diurnal saliva samples to determine changes in salivary immunoglobulin A and salivary cortisol. All data were collection was through non-evasive procedures and were assessed at baseline, end of the school semester (12 weeks) and 18 weeks. Participants, diverse university students, had no prior exposure to Tamarkoz®.
Interventions
- BEHAVIORAL Tamarkoz®
- BEHAVIORAL Stress management resources
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2015-08-24 |
| Est. Completion | 2016-02-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03489148
The ClinicalTrials.gov registry entry for NCT03489148 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tamarkoz® is the first listed.
NCT03489148 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03489148 about?
NCT03489148 is a clinical study titled "Implications of Tamarkoz® on Stress, Emotion, Spirituality and Heart Rate". Depression, anxiety, hopelessness, poor sleep quality, somatic pain, high risk of substance abuse, and suicide ideation are positively correlated with perceived stress. Spirituality and positive emotions have profound, positive impacts on health and reduce perceived stress. The current study is an e...
What is the current status of trial NCT03489148?
This trial is currently completed. It is a NA study. The enrollment target is 103 participants. The study started on 2015-08-24. Estimated completion is 2016-02-04.
What interventions are being tested in trial NCT03489148?
The interventions under investigation include: Tamarkoz® (BEHAVIORAL), Stress management resources (BEHAVIORAL).
Who is sponsoring clinical trial NCT03489148?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.